S

Smith & Nephew plc
D

SNN

24.890
USD
-0.56
(-2.18%)
مغلق
حجم التداول
20,004
الربح لكل سهم
2
العائد الربحي
2.95
P/E
36
حجم السوق
10,851,802,425
نظرة عامةالتوصياتالأفكار والتحليلاتالأخبار
أصول ذات صلة
    ABBV
    ABBV
    -2.390
    (-1.36%)
    173.030 USD
    AMGN
    AMGN
    -7.11
    (-2.67%)
    258.81 USD
    BMY
    BMY
    -0.830
    (-1.44%)
    56.830 USD
    GILD
    GILD
    -2.130
    (-2.30%)
    90.630 USD
    GSK
    GSK
    -0.545
    (-1.59%)
    33.690 USD
    JNJ
    JNJ
    -1.660
    (-1.13%)
    144.730 USD
    LLY
    LLY
    -13.61
    (-1.75%)
    764.69 USD
    MRK
    MRK
    -1.770
    (-1.77%)
    98.300 USD
    NVS
    NVS
    -2.350
    (-2.37%)
    96.820 USD
    PFE
    PFE
    -0.560
    (-2.12%)
    25.870 USD
    المزيد
الأخبار

العنوان: Smith & Nephew plc

القطاع: Healthcare
الصناعة: Medical Devices
Smith & Nephew designs, manufactures, and markets orthopedic devices, sports medicine and arthroscopic technologies, and wound care solutions. Roughly 41% of the UK-based firm's revenue comes from orthopedic products, and another 30% is sports medicine and ENT. The remaining 29% of revenue is from the advanced wound therapy segment. Over half of Smith & Nephew's total revenue comes from the United States, just over 30% is from other developed markets, and emerging markets account for the remainder.